Crystal Coma is an indica-dominant hybrid built for growers who want maximum resin and a deeply sedating finish. Born from a cross of White Widow and Northern Lights, this strain locks in roughly 70% indica genetics, THC levels in the 20–24% range, and barely measurable CBD. The feminized seed format removes male plants from the equation, making it a clean pick for indoor and small-space cultivation. Buyers get tested genetics, stealth packaging across the EU, and a germination guarantee on every order, making Crystal Coma a reliable choice for both first-time hybrid growers and seasoned home cultivators chasing trichome-heavy yields.
Crystal Coma was developed by crossing two of the most copied genetics in modern cannabis history: White Widow and Northern Lights. The line was stabilized by European breeders during the late 2000s, with several backcross generations used to lock in the heavy trichome production that gave the strain its name. Today the cross is treated as a benchmark for resinous indica hybrids in Dutch and Spanish seed catalogs.
White Widow contributes the visible frost layer, an aromatic terpene base, and a track record of stable feminized expressions. Its genetics push trichome density on calyxes and sugar leaves to levels rarely seen outside trichome-focused crosses, which is exactly what hash and rosin makers look for in a base plant.
Northern Lights brings structural reliability — short internodes, predictable bud sites, and a flowering window that closes on time. It also carries the foundational indica stone that gives Crystal Coma its sedative tail, balancing the slightly more energetic White Widow influence in the early minutes after consumption.
The current Crystal Coma line sits at roughly 70% indica and 30% sativa. Compact size, dense flowers, and an 8–9 week flowering window make it a standard choice in commercial European catalogs aimed at home growers who want premium trichome coverage without long-cycle Haze genetics.
White Widow's role in the cross is mostly aromatic and visual. It hands down the milky-frost coverage that makes Crystal Coma photograph well, plus a layered terpene profile heavy in earthy and pine notes. Its stress tolerance during late flowering is also part of why the cross holds up under imperfect humidity control.
Northern Lights anchors the structure and the timeline. Plants finish in roughly 56–63 days indoors, internodes stay tight, and side branches develop strong enough to hold dense colas without staking. That predictability is the reason the strain is recommended to growers stepping up from autoflowers to their first photoperiod hybrid.
The high comes on within five to ten minutes of inhalation, opening with a mild euphoric lift that smooths out tension in the shoulders and jaw. The first phase is sociable but not racy, which makes it easier for new users to dose without anxiety creeping in.
Around the 30-minute mark the body load deepens and the experience tilts toward heavy sedation. Most users report two to four hours of total duration, with the back half best suited to a couch, a film, or the last hours before sleep. Evening and post-dinner use is the standard recommendation.
Average THC sits in the 20–24% range across phenotypes, which places Crystal Coma firmly in the strong-but-not-extreme bracket. Experienced consumers handle it without trouble, while new users should keep doses small to avoid the typical side effects: dry mouth, dry eyes, and a pull toward sleep that arrives faster than expected.
The strain has a niche reputation among medical patients dealing with insomnia and chronic muscle tension, where its strong indica finish becomes the main therapeutic feature rather than a recreational quirk. CBD remains under 1%, so the relief comes primarily from the THC and terpene synergy.
The cannabinoid and terpene chart below is based on lab panels from multiple Crystal Coma harvests. Numbers vary slightly by phenotype and grower, but the ranges below cover the bulk of what testing has reported across European harvests.
Reading this table is most useful for growers planning extraction or for medical users matching a strain to a desired effect. THC is the headline cannabinoid here, while myrcene leads the terpene side and explains the strain's sedative pull.
| Compound | Concentration Range | Effect Contribution |
|---|---|---|
| THC | 20–24% | Primary psychoactive driver, body and head effects |
| CBD | 0.1–0.6% | Minor entourage role, no significant CBD therapy use |
| CBG | 0.3–0.8% | Minor anti-inflammatory contribution |
| Myrcene | 0.6–1.1% | Sedation, muscle relaxation, couch-lock |
| Limonene | 0.2–0.5% | Mood lift in the first 15 minutes |
| Caryophyllene | 0.3–0.6% | Anti-inflammatory action, peppery aroma |
Crystal Coma sits at a beginner-to-intermediate difficulty level. The plants are forgiving on most parameters, which is why the strain often appears in starter kits aimed at growers running their first photoperiod cycle. SOG, SCROG, and basic LST all work well thanks to the flexible side branching.
Light demand is moderate to high. A 600W LED quantum board over one square meter is enough to push the strain into its upper yield range, while 400W setups will still produce respectable returns at slightly lower density. Temperatures should stay between 20 and 24°C during flowering, with humidity dropped from 60% in vegetation to 40–45% in late bloom.
Nutrient sensitivity is the one quirk worth flagging. Crystal Coma reacts poorly to nitrogen overfeeding and will show clawed tips and dark green leaves long before any genuine deficiency appears. Keeping EC moderate — around 1.4 in vegetation and 1.8 in mid-flower — produces cleaner results than aggressive feeding schedules.
The plant performs in soil, coco coir, and hydroponic systems. Soil gives the most aromatic finish, coco produces the fastest growth, and DWC delivers the highest yields at the cost of greater pH monitoring. All three are valid, and choice usually comes down to grower preference rather than strain limitations.
Outdoor performance is best in Mediterranean and Central European climates, where harvest lands in late September or early October. Plants started in May after the last frost will reach 140–180 cm and produce dense, resin-heavy colas if rainfall stays moderate during the final flowering weeks.
The main outdoor risk is bud rot. Crystal Coma's flower density makes the larger colas vulnerable to mold during humid stretches, so growers should defoliate heavily in late flower and consider shelter for plants exposed to autumn rain. Wind protection matters less than overhead cover.
The numbers below summarize what Crystal Coma typically delivers across indoor and outdoor setups. Indoor figures assume 600W LED lighting, a stable climate, and a SCROG canopy. Outdoor figures assume Central or Southern European conditions with no major weather disruption.
Yield ranges are intentionally given as a span rather than a single number — actual results depend heavily on training method, pot size, and feeding precision. Less experienced growers should expect the lower end of each range on their first cycle.
| Parameter | Indoor | Outdoor |
|---|---|---|
| Flowering period | 8–9 weeks | Finishes late September to early October |
| Total cycle from seed | 13–15 weeks | Seed in May, harvest in October |
| Yield per m² / per plant | 450–550 g per m² | 500–700 g per plant |
| Plant height range | 90–130 cm | 140–180 cm |
| Optimal harvest window | Day 56–63 of flowering | Late September to first week of October |
| Trichome maturity indicator | Mostly milky with 10–20% amber | Mostly milky with 15–25% amber |
| Recommended drying time | 10–14 days at 18–20°C | 10–14 days at 18–20°C |
If Crystal Coma's heavy trichome coverage and indica-led finish appeal to you, the strains below share overlapping genetics, similar resin production, or comparable cultivation profiles. Each one offers a different angle on the same trichome-rich, hash-friendly direction.
We've reserved a special discount on your first SEEDS order — but it expires soon.